Clinical trial
A 48 Week Study Comparing Treatment With Saquinavir + Lopinavir/Ritonavir in…
NCT00100984 · Hoffmann-La Roche, Industry · Terminated
Key facts
| NCT number | NCT00100984 |
|---|---|
| Title | A 48 Week Study Comparing Treatment With Saquinavir + Lopinavir/Ritonavir in Combination With Enfuvirtide HAART Versus Saquinavir + Lopinavir/Ritonavir + Other Nucleoside Combinations to See the Efficacy of These Treatments in Patients Infected With HIV-1 |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV Infection |
| Intervention type | Drug |
| Interventions | FUZEON [enfuvirtide] |
| Enrollment | 8 |
| Start date | Jul 21, 2004 |
| Primary completion | Jul 16, 2005 |
| Completion | Jul 16, 2005 |
| First posted | Jan 10, 2005 |
| Last update posted | Jun 20, 2017 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: